Expediting Psychedelics Approvals In The US And Canada
By Kimberly Chew, Ana Dukic and Sabrina Ramkellawan · January 30, 2024, 5:59 PM EST
In recent years, a growing body of psychedelic clinical trials has emerged, concentrating on addressing pressing unmet needs in areas such as post-traumatic stress disorder, treatment-resistant depression, and substance use disorder,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login